![]() |
市场调查报告书
商品编码
1603871
2030年冬虫夏草市场预测:依产品类型、来源、通路、应用、最终用户和地区进行全球分析Cordyceps Militaries Market Forecasts to 2030 - Global Analysis By Product Type (Powder, Capsules, Extracts, Whole Mushroom, Liquid Form and Other Product Types), Source Type, Distribution Channel, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球冬虫夏草市场规模为 10 亿美元,预计到 2030 年将达到 24 亿美元,预测期内复合年增长率为 14.8%。
冬虫夏草是一种以其药用特性而闻名的寄生真菌。它主要针对昆虫,感染它们,并最终损害宿主。它在传统医学中得到广泛认可,特别是在中国和西藏文化中,并被认为可以增强能量、增强耐力并支持免疫功能。人们已经研究了虫草素等生物活性化合物的潜在发炎、抗氧化和抗癌作用。现代研究不断深入研究其治疗应用,导致人们对健康和保健领域的兴趣日益浓厚。
根据世界卫生组织(WHO)的数据,全球18岁以上人口的糖尿病盛行率从1980年的4.7%上升到2014年的8.5%。
对自然疗法的需求不断增长
消费者对整体健康和替代疗法的兴趣日益浓厚,导致市场对自然疗法的需求大幅增加。随着人们寻求永续的植物来源选择来增强能量、免疫力和整体健康,冬虫夏草因其药用特性而越来越受欢迎。需求的激增也促使人们越来越认识到传统和现代健康实践的潜在发炎、抗氧化和提高性能的作用。
消费者意识有限
市场上的消费者意识有限,许多人仍然不知道其健康益处和用途,阻碍了市场成长潜力。这种知识的缺乏减少了产品需求,并使公司难以充分利用其市场潜力。此外,对冬虫夏草安全性和有效性的误解可能会阻碍其吸收,阻止冬虫夏草到达更广泛的消费者群体,并限制其作为主流健康实践的广泛接受。
萃取技术的进步
萃取技术的进步显着提高了市场上产品的效率和品质。超临界二氧化碳萃取和液液萃取等现代方法可以更好地保存虫草素等生物活性化合物,从而提高补充品的功效。这些创新不仅提高了产量,还确保了更高的纯度和生物利用度,从而为传统和现代健康实践提供了优质有效的产品,满足了对天然保健产品不断增长的需求。
生产成本高
市场上的高生产成本是可扩展性和可负担性的主要障碍。复杂的种植过程和特殊的萃取方法导致产品的成本和零售价格更高。这限制了对价格敏感的消费者的可用性并限制了市场扩张。因此,这些高级产品仅供一小部分人使用,阻碍了更广泛的市场采用和成长。
COVID-19 的疫情对市场产生了各种影响。一方面,对免疫支持和自然疗法的日益关注增加了对含有冬虫夏草的膳食食品的需求。同时,供应链中断、产能下降和物流挑战减缓了成长。此外,经济不确定性和消费者支出减少限制了优质冬虫夏草产品的承受能力,影响了整体市场表现。
胶囊细分市场预计将在预测期内成为最大的细分市场
由于其方便且易于食用,预计在预测期内胶囊将占据最大的市场占有率。冬虫夏草胶囊提供精确的剂量,为消费者提供了一种将真菌的健康益处(例如增强能量、免疫支持和发炎特性)融入日常生活的简单方法。随着越来越多的人寻求无忧、标准化和有效的天然健康解决方案,胶囊产品的需求量很大。
预计製药业在预测期内复合年增长率最高。
预计製药业在预测期内复合年增长率最高。对冬虫夏草发炎、抗癌和增强免疫作用的研究引起了製药业的兴趣,导致了基于冬虫夏草的药物和治疗方法的开发。这项变化的推动因素是消费者对有科学依据的自然疗法的需求不断增长,以及支持冬虫夏草药用潜力的临床证据的累积。
预计北美地区在预测期内将占据最大的市场占有率。人们越来越认识到冬虫夏草的功效,例如增强免疫力和提高运动表现,导致对冬虫夏草产品(包括胶囊和粉末)的需求增加。此外,植物来源机能性食品市场的扩张进一步提高了其受欢迎程度,使北美成为关键成长地区。
由于膳食食品需求的增加,预计亚太地区在预测期内将出现最高的成长率。随着人口老化的增长,人们对促进长寿和整体健康的产品(例如冬虫夏草)的兴趣将会增加。可支配所得的增加和中阶的壮大使消费者更重视健康。人们越来越多地转向天然和有机产品,包括提供多种健康益处的营养食品,例如增强能量和支持免疫系统。
According to Stratistics MRC, the Global Cordyceps Militaries Market is accounted for $1.0 billion in 2024 and is expected to reach $2.4 billion by 2030 growing at a CAGR of 14.8% during the forecast period. Cordyceps militaris is a parasitic fungus known for its medicinal properties. It primarily targets insects, infecting them and ultimately consuming their host. Widely recognized in traditional medicine, particularly in Chinese and Tibetan cultures, it's believed to boost energy, enhance stamina, and support immune function. Its bioactive compounds, such as cordycepin, have been studied for potential anti-inflammatory, antioxidant, and anti-cancer effects. Modern research continues to delve into its therapeutic applications, making it a subject of growing interest in health and wellness circles.
According to the World Health Organization (WHO), the global prevalence of diabetes among individuals over 18 years old increased from 4.7% in 1980 to 8.5% in 2014.
Increasing demand for natural remedies
The demand for natural remedies has significantly increased in the market, driven by growing consumer interest in holistic health and alternative treatments. As people seek plant-based, sustainable options to enhance energy, immunity, and overall well-being, Cordyceps militaris has gained popularity due to its reputed medicinal benefits. This surge in demand is also fueled by rising awareness of its potential anti-inflammatory, antioxidant, and performance-enhancing properties in both traditional and modern wellness practices.
Limited Consumer Awareness
Limited consumer awareness in the market hinders its growth potential, as many people remain unaware of its health benefits and uses. This lack of knowledge reduces demand for products, making it challenging for companies to fully capitalize on the market's potential. Additionally, misconceptions about its safety or efficacy may discourage adoption, preventing Cordyceps militaris from reaching a broader consumer base and limiting its widespread acceptance in mainstream wellness practices.
Advancements in extraction techniques
Advancements in extraction techniques have significantly improved the efficiency and quality of products in the market. Modern methods like supercritical CO2 extraction and liquid-liquid extraction allow for better preservation of bioactive compounds, such as cordycepin, enhancing the potency of supplements. These innovations not only improve yields but also ensure higher purity and bioavailability, meeting the increasing demand for high-quality, effective natural health products in both traditional and contemporary wellness sectors.
High Production Costs
High production costs in the market pose a significant barrier to scalability and affordability. The complex cultivation process, along with specialized extraction methods, contributes to elevated costs, which in turn increases the retail price of products. This limits accessibility for price-sensitive consumers and restricts market expansion. As a result, only a small segment of the population can afford these premium products, hindering broader market adoption and growth.
The COVID-19 pandemic had a mixed impact on the market. On one hand, the growing focus on immune support and natural remedies led to increased demand for health supplements containing Cordyceps. On the other hand, supply chain disruptions, reduced production capacity, and logistical challenges slowed growth. Additionally, economic uncertainty and consumer spending cuts limited the affordability of premium Cordyceps-based products, affecting overall market performance.
The capsules segment is projected to be the largest during the forecast period
The capsules segment is projected to account for the largest market share during the projection period due to their convenience and ease of consumption. Offering a precise dosage, Cordyceps capsules provide consumers with a simple way to incorporate the fungus's health benefits, such as enhanced energy, immune support, and anti-inflammatory properties, into their daily routines. The demand for capsule-based products is growing as people seek hassle-free, standardized, and effective natural health solutions.
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period
The pharmaceuticals segment is expected to have the highest CAGR during the extrapolated period. Research into its anti-inflammatory, anti-cancer, and immune-boosting properties has spurred interest from the pharmaceutical industry, leading to the development of Cordyceps-based drugs and treatments. This shift is driven by growing consumer demand for natural, scientifically-backed remedies and the expanding body of clinical evidence supporting Cordyceps' medicinal potential.
North America region is projected to account for the largest market share during the forecast period. As awareness of the fungus' benefits such as boosting energy, supporting immunity, and improving athletic performance grows, demand for Cordyceps based products, including capsules and powders, is rising. Additionally, the expanding market for plant-based and functional foods has further propelled its popularity, positioning North America as a key growth region.
Asia Pacific is expected to register the highest growth rate over the forecast period due to increase demand for health supplements. As the elderly population grows, there will be a higher interest in products that promote longevity and overall health, such as Cordyceps Militaris With increasing disposable incomes and a growing middle class, consumers are becoming more health-conscious. There is a notable shift towards natural and organic products, including dietary supplements that promise various health benefits such as enhanced energy and immune support.
Key players in the market
Some of the key players in Cordyceps Militaries market include Yuming Biotechnology, Beijing Jingdu Cordyceps Biotech Co. Ltd., Bulk Natural Foods, Odyssey , Lotos Phytochem, Sun Mushrooms LLC, The Fungi Kingdom, Beta Glucan Products, Nutra Green Biotechnology Co., Ltd., Xi'an Saina Biological Technology Co., Ltd., Dalong Biotechnology Co., Ltd., Health Choice Limited, Sunrise Nutrachem Group Ltd., EcoFungi and Platinum Mushrooms.
In February 2024, Odyssey received USD 6 million in investment for its mushroom-infused energy drinks. The brand offers pre-made beverages mixed with Lions Mane and Cordyceps mushrooms to enhance cognitive performance.
In June 2023, Awshad, a New Delhi-based medicinal cannabis wellness firm, introduced its first product, 'Calmashroom Vijaya and Cordyceps Capsules.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.